Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding
Mother-to-child-transmission rates of HIV in the absence of any intervention range between 20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy, delivery and breastfeeding can reduce HIV transmission to less than 2%. Physiological changes during pregnancy can influence...
Saved in:
Main Authors: | Adeniyi Olagunju, Andrew Owen, Tim R. Cressey |
---|---|
格式: | 雜誌 |
出版: |
2018
|
主題: | |
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84867567023&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51353 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Chiang Mai University |
相似書籍
-
Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding
由: Olagunju A., et al.
出版: (2017) -
Pharmacokinetic optimization of antiretroviral therapy in pregnancy
由: Kajal Buckoreelall, et al.
出版: (2018) -
Pharmacogenetics and the prevention of mother-to-child transmission of HIV
由: Tim R. Cressey, et al.
出版: (2018) -
The role of formulation on the pharmacokinetics of antiretroviral drugs
由: Diane Et Bastiaans, et al.
出版: (2018) -
Efavirenz pharmacokinetics during pregnancy and infant washout
由: Regis Kreitchmann, et al.
出版: (2019)